POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 94 filers reported holding POSEIDA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,539 | +35.8% | 14,512 | +0.4% | 0.00% | – |
| Q2 2023 | $25,438 | -52.0% | 14,454 | +21.9% | 0.00% | – |
| Q1 2022 | $53,000 | -48.5% | 11,861 | -21.4% | 0.00% | – |
| Q4 2021 | $103,000 | -16.9% | 15,084 | -11.3% | 0.00% | – |
| Q3 2021 | $124,000 | -33.7% | 17,002 | -8.7% | 0.00% | -100.0% |
| Q2 2021 | $187,000 | +12.7% | 18,630 | +6.9% | 0.00% | 0.0% |
| Q1 2021 | $166,000 | +21.2% | 17,434 | +39.3% | 0.00% | 0.0% |
| Q4 2020 | $137,000 | – | 12,516 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 2,945,948 | $5,184,868 | 1.60% |
| Aisling Capital Management LP | 1,043,267 | $1,836,150 | 0.90% |
| Knott David M Jr | 140,921 | $248 | 0.10% |
| XTX Topco Ltd | 233,493 | $410,948 | 0.07% |
| Pentwater Capital Management LP | 5,975,000 | $10,516,000 | 0.07% |
| Atom Investors LP | 49,413 | $86,967 | 0.03% |
| EcoR1 Capital, LLC | 676,296 | $1,190,281 | 0.03% |
| Forefront Analytics, LLC | 26,619 | $46,850 | 0.03% |
| FNY Investment Advisers, LLC | 11,500 | $20 | 0.02% |
| CORNERCAP INVESTMENT COUNSEL INC | 80,979 | $142,523 | 0.02% |